产品名称 | NebuSelect™ Recombinant SARS-COV-2 Spike RBD (N501Y), His-tag |
---|---|
目录号 | NBL-242796 |
别名 | Spike RBD (N501Y); S protein RBD; S glycoprotein RBD; Spike protein RBD |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | QHD43416.1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242796-100ug | 100ug | Inquire | Inquire | |
NBL-242796-1mg | 1mg | Inquire | Inquire | |
NBL-242796-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant SARS-COV-2 Spike RBD (N501Y), His-tag
Catalog#:
NBL-242796
Description:
NebuSelect™ Recombinant SARS-COV-2 Spike RBD (N501Y), His-tag(Cat#NBL-242796) is expressed in HEK293 with His tag at the C-Terminus.It contains Arg319-Phe541(N501Y).
Species:
SARS-COV-2
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 26.2 kDa. Due to glycosylation, the protein migrates to 36-40 kDa based on Bis-Tris PAGE result.
Target Name:
Spike RBD (N501Y); S protein RBD; S glycoprotein RBD; Spike protein RBD
Target Information:
The ongoing coronavirus disease 2019 (COVID-19) pandemic has prioritized the development of small-animal models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The resulting mouse-adapted strain at passage 6 (called MASCp6) showed increased infectivity in mouse lung and led to interstitial pneumonia and inflammatory responses in both young and aged mice after intranasal inoculation. Deep sequencing revealed a panel of adaptive mutations potentially associated with the increased virulence. In particular, the N501Y mutation is located at the receptor binding domain (RBD) of the spike protein.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.